CSI Market
Sign In | Register

Vor Biopharma Inc (VOR) Annual Balance Sheets

Annual · GAAP · USD millions
Access VOR quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Vor Biopharma Inc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent396.49
Marketable Securities, Current SH58.72
Cash & Short-term Investments454.00
Other Current Assets1.75
Prepaid Expense, Current AS1.15
Total Current Assets458.11
Equipment/Property/Plant Net0.53
Other Assets, Noncurrent5.49
Restricted Cash Equivalents Noncurrent0.17
Operating Lease Right Of Use Asset2.94
Total Assets464.13
Liabilities
Accounts Payable, Current AC5.13
Accrued Liabilities, Current AC19.76
Other Liabilities, Current0.00
Total Current Liabilities25.17
Total Long-term Debt0.00
Other liabilities, Noncurrent603.27
Operating Lease Liability Current0.28
Total Liabilities628.44
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock988.60
Retained Earnings / Accumulated Deficit-1,152.98
Other Equity0.04
Common Stockholder's Equity-164.31
Total Stockholder's Equity-164.31
Liabilities & Stockholder's Equity464.13
4 historic quarters locked

Sign in to unlock the full Vor Biopharma Inc balance sheet history.

Sign In Create Free Account

About Vor Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 30, 2026
  • Source: vor-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-130451

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.